Corona Remedies Limited will host an analyst and investor conference call on August 3, 2026, to discuss its financial results for the first quarter ended June 30, 2026. The meeting is scheduled to begin at 11:30 AM IST and will provide a detailed review of the company's performance for Q1 FY27.

The disclosure was made pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The intimation is available on the company's official website.

The management team will be represented by key executives, including Mr. Nirav Mehta, Managing Director & CEO, Mr. Ankur Mehta, Joint Managing Director, and Mr. Bhavin Bhagat, Chief Financial Officer.

Conference Call Details

Participants can join the discussion via universal dial-in numbers or international toll-free lines. For further information, stakeholders may contact Mr. Rohit Bhat or Mr. Maulik Varia at 360 ONE Capital Market Research.

Corona Remedies Ltd declared a final dividend of ₹10 per share for the financial year 2025-26 at its 22nd Annual General Meeting held on July 09, 2026. The meeting, conducted via video conferencing, saw the approval of the audited financial statements for the year ended March 31, 2026, and the re-appointment of statutory auditors and directors. All nine proposed resolutions were passed with the requisite majority through remote e-voting and e-voting conducted during the meeting.

Key Resolutions Passed

The shareholders approved a final dividend of ₹10 per equity share, representing a 100% payout on the face value of ₹10 each for F.Y. 2025-26. The resolution received 100% of the votes cast in favour.

Appointments and Ratifications

The meeting resulted in the appointment of M/s. Walker Chandiok & Co LLP as Statutory Auditors and M/s. Dhara Patel, Company Secretary Firm, as Secretarial Auditors. Additionally, the remuneration payable to Cost Auditors for F.Y. 2026-27 was ratified.

Director Re-appointments

Mr. Nirav Mehta (DIN: 01644041) was re-appointed as a Director, having retired by rotation. Dr. Kirtikumar Mehta (DIN: 00385658) was re-appointed as Non-Executive Director and Chairman for a term of five years. The meeting also approved the payment of commission to Non-Executive Directors and remuneration to Dr. Kirtikumar Mehta for the Financial Year 2026-27.

Voting Results Summary

The remote e-voting facility was open from July 06, 2026 to July 08, 2026. The Scrutinizer's Report, issued by M/s. Dhara Patel, Company Secretary Firm, confirmed the results. The AGM commenced at 11:00 a.m. and concluded at 12:15 p.m.